Skip to content
12005-D-EMEA_Recomb-Antibody_LP-Hero-Lrg@3x

Recombinant Antibody Production In As Fast As 8 Business Days

Save time and accelerate your research with recombinant antibody production services from GENEWIZ. We support you at every step - from optimizing your antibody sequences to delivering purified antibodies - saving you weeks of hands-on work with flexible, tailored solutions designed around your specific needs.

RECOMBINANT ANTIBODY PRODUCTION WORKFLOW

Accelerate Your Research With Confidence

FAST AND RELIABLE

Industry-leading turnaround time starting at 2 weeks, including DNA synthesis to purified recombinant mAbs.

End-to-end service: Gene to purified antibody

PROVEN PERFORMANCE

Strong expression for mAbs & bispecifics.

Supports complex and GC-rich constructs

 

FLEXIBLE AND SCALABLE

 Choose the format you need - IgG,
ScFv, Fab, bispecifics, VHH, and
more - we deliver with precision. 

RIGOROUS QC

High purity with comprehensive QC & CoA

EXPERT SUPPORT

Real-time consultation with PhD-level scientists . 

rAB-Application-Note-Thumbnail

​Application Note | Accelerating Recombinant Antibody Production
Recombinant antibody production is a cornerstone of modern biotechnology and research, but it faces the significant challenge of achieving high yields. In this application note, discover how to enhance expression efficiency while reducing production times with an optimized vector backbone workflow.

Explore Our Antibody Solutions

Discover antibody leads that you may have missed with advanced technologies that uncover 5-10 times more functionally diverse candidates.


SYNTHETIC DNA LIBRARIES
High diversity, up to 10^12,
depending on library type, for more efficient antibody screening.

OLIGO CLONED LIBRARIES
Synthesize large oligo pools with
precise diversity and clone into
vectors with >95% accuracy.
HYBRIDOMA SEQUENCING
Immune profiling using
NGS allows for ultra-deep
immune repertoire analysis.

MACHINE LEARNING
Prioritize leads with the most
favorable developability and
biophysical profiles.
NEXT-GENERATION SEQUENCING
NGS technologies, including the new Illumina® NovaSeq® X series and PacBio® Revio™ platforms, ensure top-quality candidates are selected.
RCA TO SANGER & WHOLE
PLASMID SEQUENCING
Use colony or phage sequencing to rapidly identify clones. Extremely effective with low amounts of DNA.

ANTIBODY DNA SYNTHESIS
Gene synthesis with codon optimization
for expression and purification of
desired antibodies.
RECOMBINANT ANTIBODY PRODUCTION
Precision-driven production of
scalable, reliable antibodies.

Register now for the Limited-time Special Gene-to-Antibody Discount

Terms and conditions:

  • This promotion is only valid until 30 June 2026.
  • The stated TAT applies only to mAb (variable region synthesis < 500 bp). For full-length synthesis, a minimum of 5 business days is required. The specific TAT for such projects will be subjected on a case-by-case basis.
  • Additional fee applies for shipping services.
  • Eligibility: This promotional price is applicable exclusively to end users based in South Korea. 
  • Limited to single use per customer.
  • Terms and conditions are subjected to change without further notice. Please refer to this webpage for latest updates.